Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


Discovery Chemistry & Drug Design Congress 2013

10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland



Bookmark and Share


Oxford Global Conferences are proud to present the Discovery Chemistry & Drug Design Congress taking place on 10 & 11 June in Geneva. This congress is the latest addition to our long-established 14th Annual Drug Discovery Summit. Focused on the latest breakthroughs in discovery chemistry, it will bring together the industry leaders in medicinal chemistry and drug design.

The discovery industry faces a decade of monumental change – stem cell research, gene therapy approvals, virtual R&D models and a growing focus on biological pipelines are just a few of the factors changing the way we approach drug discovery. Our expert speaker panel will explore the critical concerns in discovery chemistry today, while updating key decision makers on the latest developments in drug design.

Day One will feature presentations on lead optimisation, structure-activity relationships and fragment-based drug discovery. Our internationally renowned speakers will also discuss the latest developments in drug design, including anti-target modelling, advances in polypharmacology and structure based design.

The event will be co-located with the Innovation Driven Discovery Congress; a high-level meeting focused on novel approaches to drug discovery and collaborative working methods. Delegates will also be able to attend the co-located Drug Development Congress; a two stream event for those working at the forefront of research, development and translational medicine.



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Sanger Institute, St Jude Data-Sharing Agreement
Childhood cancer targeted by Sanger Institute and St Jude Children’s Research Hospital exchanges of cancer data
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Space Research Fighting Cancer
JPL and National Cancer Institute renew Big Data partnership that 'learns' data similarities.
Uncovering the Genetics Behind High Blood Pressure
Results suggest a role for blood vessels themselves in controlling blood pressure.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!